Author
Han Chong Toh
Also Known As
H C Toh, H. C. Toh, H. Toh, H.C. Toh, HC Toh, Han Chong Toh, Han C Toh, Han C. Toh, Han Chong Toh, Han Toh
235
Publications
11K
Citations
52
H-Index
123
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 34 | 50 | 5.2K |
2 | Health Sciences | 12 | 12 | 868 |
3 | Natural Sciences | 2 | 2 | 250 |
4 | Engineering | 1 | 1 | 73 |
5 | Public Health | 1 | 1 | 13 |
Han Chong Toh
×
103
Publications
9.6K
Citations
49
H-Index
| Year | Citations | |
|---|---|---|
2012 | 635 | |
2022 | 580 | |
2015 | 454 | |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma | 2023 | 415 |
2011 | 372 | |
2011 | 363 | |
2018 | 355 | |
2006 | 291 | |
2019 | 277 | |
2009 | 254 |
Page 1
Page 1